Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Covid and the rest: An opinionated take on NEJM highlights for April 2020

  • NEJM
Hydroxychloroquine does not seem to help much in Covid-19 (with caveat…

Read more